NCT01400958View on ClinicalTrials.gov

Nuvigil or Placebo in Newly Diagnosed Malignant Glioma

PHASE2TerminatedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

September 30, 2013

Conditions

Malignant Glioma

Interventions

DRUG

Nuvigil®

Nuvigil® 150 mg/day x 42 days THEN, No More Drug

DRUG

Placebo

Placebo x 42 days; THEN, No More Placebo

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Cephalon

INDUSTRY

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER